Auburn Hills, MI, United States of America

Thomas Ohl

This inventor holds 1 USPTO granted patent. Top assignee: Evonik Roehm Gmbh. Active years: 2016.


Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Thomas Ohl - Innovator in Bicyclic and Tricyclic (Meth)Acrylates

Introduction

Thomas Ohl is a notable inventor based in Auburn Hills, MI (US). He has made significant contributions to the field of chemical engineering, particularly in the production of bicyclic and tricyclic (meth)acrylates. His innovative approach has led to advancements in the synthesis of these important compounds.

Latest Patents

Thomas Ohl holds a patent for a "Method for producing bicyclic or tricyclic (meth)acrylates." This process involves preparing bicyclic or tricyclic (meth)acrylates by reacting (meth)acrylic acid with a bicyclic or tricyclic hydrocarbon that contains at least one double bond, utilizing montmorillonite as a catalyst. This patent showcases his expertise and creativity in chemical processes.

Career Highlights

Ohl is currently employed at Evonik Roehm GmbH, where he continues to apply his knowledge and skills in the field. His work at this esteemed company has allowed him to further develop his innovative ideas and contribute to the advancement of chemical manufacturing.

Collaborations

Throughout his career, Thomas Ohl has collaborated with talented individuals such as Joachim Knebel and Thorben Schuetz. These partnerships have fostered a creative environment that encourages the exchange of ideas and the development of groundbreaking technologies.

Conclusion

In summary, Thomas Ohl is a distinguished inventor whose work in the production of bicyclic and tricyclic (meth)acrylates has made a significant impact in the field of chemical engineering. His innovative methods and collaborations continue to drive advancements in this area.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…